Institutional members access full text with Ovid®

Share this article on:

Association Study of 71 European Crohn's Disease Susceptibility Loci in a Japanese Population

Hirano, Atsushi MD*,†; Yamazaki, Keiko DVM, PhD*; Umeno, Junji MD, PhD*,†; Ashikawa, Kyota MS*; Aoki, Masayuki MD, PhD*; Matsumoto, Takayuki MD, PhD; Nakamura, Shotaro MD, PhD; Ninomiya, Toshiharu MD, PhD; Matsui, Toshiyuki MD, PhD§; Hirai, Fumihito MD, PhD§; Kawaguchi, Takaaki MD; Takazoe, Masakazu MD; Tanaka, Hiroki MD, PhD; Motoya, Satoshi MD, PhD; Kiyohara, Yutaka MD, PhD; Kitazono, Takanari MD, PhD; Nakamura, Yusuke MD, PhD**; Kamatani, Naoyuki MD, PhD*; Kubo, Michiaki MD, PhD*

doi: 10.1097/MIB.0b013e31828075e7
Original Basic Science Articles

Background: A large-scale meta-analysis of a series of European genome-wide association studies revealed 71 susceptibility loci for Crohn's disease (CD). However, it is not clear whether these susceptibility loci are also shared with Japanese populations.

Methods: We genotyped 71 single-nucleotide polymorphisms (SNPs) comprising 1311 CD cases and 6585 controls of Japanese descent, and their associations with CD were evaluated using the Cochran–Armitage trend test. In addition, genotype–phenotype analyses were conducted on the SNPs showing associations with Japanese CD based on the Montreal classification.

Results: Twenty-seven SNPs showed at least nominal association (P < 0.05) and 11 of them remained significant even after Bonferroni correction (P < 0.0007). Despite high statistical power, we could not find any association in 17 loci. Moreover, SNPs in 9 loci were rare or absent in the Japanese population. Genetic variations involved in the innate immune system (NOD2, ATG16L1, and IRGM) showed no association with CD susceptibility in the Japanese population. Genotype–phenotype analyses showed that rs3810936, a marker of TNFSF15, correlated with severe CD phenotypes.

Conclusions: Our study suggests that there is a differential genetic background of CD susceptibility between Japanese and European populations.

Supplemental Digital Content is Available in the Text.Article first published online 6 February 2013

*Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN Yokohama Institute, Yokohama, Japan

Department of Medicine and Department of Clinical Science,

Department of Environmental Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

§Department of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan

Department of Medicine, Division of Gastroenterology, Social Insurance Chuo General Hospital, Tokyo, Japan

Department of Gastroenterology, Sapporo-Kosei General Hospital, Sapporo, Japan

**Human Genome Center, Institute of Medical Science, the University of Tokyo, Tokyo, Japan.

Reprints: Michiaki Kubo, MD, PhD, Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN Yokohama Institute, 1-7-22, Suehiro-cho, Tsurumi, Yokohama, Kanagawa 230-0045, Japan (e-mail: mkubo@src.riken.jp).

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (http://www.ibdjournal.org).

The authors have no conflicts of interest to disclose.

This work was conducted as a part of the BioBank Japan Project and supported by a Grant-in-Aid for Young Scientists (A) (22689025) from the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.

Received July 26, 2012

Accepted August 04, 2012

© Crohn's & Colitis Foundation of America, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website